ARTICLE | Financial News
Cerus planning follow-on
March 14, 2013 12:30 AM UTC
Cerus Corp. (NASDAQ:CERS) proposed late Wednesday a follow-on underwritten by Cowen. Cerus markets the Intercept Blood System to inactivate blood-borne pathogens in donated blood components intended f...